170 related articles for article (PubMed ID: 34833498)
21. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
[TBL] [Abstract][Full Text] [Related]
22. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
Fishel ML; Kelley MR
Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of stimulation of DNA binding of the transcription factors by human apurinic/apyrimidinic endonuclease 1, APE1.
Bazlekowa-Karaban M; Prorok P; Baconnais S; Taipakova S; Akishev Z; Zembrzuska D; Popov AV; Endutkin AV; Groisman R; Ishchenko AA; Matkarimov BT; Bissenbaev A; Le Cam E; Zharkov DO; Tudek B; Saparbaev M
DNA Repair (Amst); 2019 Oct; 82():102698. PubMed ID: 31518879
[TBL] [Abstract][Full Text] [Related]
24. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
25. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
26. Dual Function of Secreted APE1/Ref-1 in TNBC Tumorigenesis: An Apoptotic Initiator and a Regulator of Chronic Inflammatory Signaling.
Choi S; Lee YR; Kim KM; Choi E; Jeon BH
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012284
[TBL] [Abstract][Full Text] [Related]
27. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
29. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.
Ando K; Hirao S; Kabe Y; Ogura Y; Sato I; Yamaguchi Y; Wada T; Handa H
Nucleic Acids Res; 2008 Aug; 36(13):4327-36. PubMed ID: 18586825
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
Zhang Y; You H; Duan J; Gao Y
Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
[TBL] [Abstract][Full Text] [Related]
31. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.
Fishel ML; Colvin ES; Luo M; Kelley MR; Robertson KA
Exp Hematol; 2010 Dec; 38(12):1178-88. PubMed ID: 20826193
[TBL] [Abstract][Full Text] [Related]
33. Redox factor-1 activates endothelial SIRTUIN1 through reduction of conserved cysteine sulfhydryls in its deacetylase domain.
Jung SB; Kim CS; Kim YR; Naqvi A; Yamamori T; Kumar S; Kumar A; Irani K
PLoS One; 2013; 8(6):e65415. PubMed ID: 23755229
[TBL] [Abstract][Full Text] [Related]
34. Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1).
Zhang Y; Wang J
Chin J Cancer; 2010 Mar; 29(3):333-9. PubMed ID: 20193121
[TBL] [Abstract][Full Text] [Related]
35. Expression of Apurinic/Apyrimidinic Endonuclease 1 in Colorectal Cancer and its Relation to Tumor Progression and Prognosis.
Hong JY; Oh HH; Park SY; Park YL; Cho SB; Joo YE
In Vivo; 2023; 37(5):2070-2077. PubMed ID: 37652525
[TBL] [Abstract][Full Text] [Related]
36. APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.
Thakur S; Sarkar B; Cholia RP; Gautam N; Dhiman M; Mantha AK
Exp Mol Med; 2014 Jul; 46(7):e106. PubMed ID: 25033834
[TBL] [Abstract][Full Text] [Related]
37. APE1/Ref-1 Inhibits Phosphate-Induced Calcification and Osteoblastic Phenotype Changes in Vascular Smooth Muscle Cells.
Lee KM; Lee EO; Lee YR; Joo HK; Park MS; Kim CS; Choi S; Jeong JO; Jeon BH
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946662
[TBL] [Abstract][Full Text] [Related]
38. Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor.
Park MS; Choi S; Lee YR; Joo HK; Kang G; Kim CS; Kim SJ; Lee SD; Jeon BH
Sci Rep; 2016 Mar; 6():23015. PubMed ID: 26964514
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional Up-Regulation of APE1/Ref-1 in Hepatic Tumor: Role in Hepatocytes Resistance to Oxidative Stress and Apoptosis.
Di Maso V; Mediavilla MG; Vascotto C; Lupo F; Baccarani U; Avellini C; Tell G; Tiribelli C; Crocè LS
PLoS One; 2015; 10(12):e0143289. PubMed ID: 26624999
[TBL] [Abstract][Full Text] [Related]
40. Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.
Jin SA; Lim BK; Seo HJ; Kim SK; Ahn KT; Jeon BH; Jeong JO
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]